Advertisement |
ChromoTek GmbH (Munich, Germany) has developed a series of highly sensitive protein-protein interaction (PPI) assays to screen compounds that resolve the binding of two proteins within cells. The so called fluorescent two hybrid (F2H®) technology is based on a proprietary cell line that contains a spot-like landing platform where one interaction partner binds.
Read Full Article